Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Carbone

Showing results (51-60 of 266) with videos related to

Pageof 27
Sort By:
World Journal of Cardiology|June 20, 2014
Potential pathophysiological role for the vitamin D deficiency in essential hypertensionFederico Carbone, François Mach, Nicolas Vuilleumier, et al.
Polish Archives of Internal Medicine|January 16, 2024
Role of glucagon-like peptide-1 receptor agonists in the treatment of obesity, cardiovascular disease, and cerebrovascular diseaseAmedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
World Journal of Cardiology|March 31, 2025
Evaluating inflammatory status to predict atrial fibrillation recurrence following ablation: The role of systemic immune-inflammation indexAmedeo Tirandi, Federico Carbone, Luca Liberale, et al.
World Journal of Cardiology|January 2, 2026
Reimagining risk stratification: Dipeptidyl peptidase 3 in the new era of cardiovascular biomarkersDavide Ramoni, Luca Liberale, Federico Carbone, et al.
International Journal of Cardiology|June 30, 2018
Reply to "Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway"Federico Carbone, Luca Liberale, Aldo Bonaventura, et al.
Minerva Cardiology and Angiology|January 11, 2021
Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damageEdoardo Elia, Stefano Ministrini, Federico Carbone, et al.
World Journal of Cardiology|February 16, 2026
Mothers against decapentaplegic homolog 4 as a proteomic hub in vascular remodeling and residual cardiovascular riskDavide Ramoni, Federico Carbone, Luca Liberale, et al.
European Journal of Clinical Investigation|April 24, 2025
Cancer and cardiovascular diseases: A deadly combinationAldo Bonaventura, Luca Liberale, Federico Carbone, et al.
CNS Drugs|September 2, 2019
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New FormulationsFederico Carbone, Atbin Djamshidian, Klaus Seppi, et al.
Biomed Research International|October 25, 2021
Effects of Curcumin on Aging: Molecular Mechanisms and Experimental EvidenceAfsane Bahrami, Fabrizio Montecucco, Federico Carbone, et al.
Pageof 27

Showing results (51-60 of 266) with videos related to

Sort By:
Pageof 27
World Journal of Cardiology|June 20, 2014
Potential pathophysiological role for the vitamin D deficiency in essential hypertensionFederico Carbone, François Mach, Nicolas Vuilleumier, et al.
Polish Archives of Internal Medicine|January 16, 2024
Role of glucagon-like peptide-1 receptor agonists in the treatment of obesity, cardiovascular disease, and cerebrovascular diseaseAmedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
World Journal of Cardiology|March 31, 2025
Evaluating inflammatory status to predict atrial fibrillation recurrence following ablation: The role of systemic immune-inflammation indexAmedeo Tirandi, Federico Carbone, Luca Liberale, et al.
World Journal of Cardiology|January 2, 2026
Reimagining risk stratification: Dipeptidyl peptidase 3 in the new era of cardiovascular biomarkersDavide Ramoni, Luca Liberale, Federico Carbone, et al.
International Journal of Cardiology|June 30, 2018
Reply to "Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway"Federico Carbone, Luca Liberale, Aldo Bonaventura, et al.
Minerva Cardiology and Angiology|January 11, 2021
Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damageEdoardo Elia, Stefano Ministrini, Federico Carbone, et al.
World Journal of Cardiology|February 16, 2026
Mothers against decapentaplegic homolog 4 as a proteomic hub in vascular remodeling and residual cardiovascular riskDavide Ramoni, Federico Carbone, Luca Liberale, et al.
European Journal of Clinical Investigation|April 24, 2025
Cancer and cardiovascular diseases: A deadly combinationAldo Bonaventura, Luca Liberale, Federico Carbone, et al.
CNS Drugs|September 2, 2019
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New FormulationsFederico Carbone, Atbin Djamshidian, Klaus Seppi, et al.
Biomed Research International|October 25, 2021
Effects of Curcumin on Aging: Molecular Mechanisms and Experimental EvidenceAfsane Bahrami, Fabrizio Montecucco, Federico Carbone, et al.
Pageof 27